Related Experiment Video
Updated: Oct 18, 2025

A General Method for Detecting Nitrosamide Formation in the In Vitro Metabolism of Nitrosamines by Cytochrome P450s
Published on: September 25, 2017
Estimated Cancer Risks Associated with Nitrosamine Contamination in Commonly Used Medications
Kate Li1, Karin Ricker1, Feng C Tsai1
1Office of Environmental Health Hazard Assessment (OEHHA), California Environmental Protection Agency, Oakland, CA 94612, USA.
Abstract:
Many nitrosamines are potent carcinogens, with more than 30 listed under California's Proposition 65. Recently, nitrosamine contamination of commonly used drugs for treatment of hypertension, heartburn, and type 2 diabetes has prompted numerous Food and Drug Administration (FDA) recalls in the US. These contaminants include the carcinogens NDMA (N-nitrosodimethylamine) and NDEA (N-nitrosodiethylamine) and the animal tumorigen NMBA (N-nitroso-N-methyl-4-aminobutyric acid). NMBA and NDEA are metabolically and/or structurally related to NDMA, an N-nitrosomethyl-n-alkylamine (NMA), and 12 other carcinogenic NMAs. These nitrosamines exhibit common genotoxic and tumorigenic activities, with shared target tumor sites amongst chemicals and within a given laboratory animal species. We use the drug valsartan as a case study to estimate the additional cancer risks associated with NDMA and NDEA contamination, based on nitrosamine levels reported by the US FDA, cancer potencies developed by California's Proposition 65 program and the US Environmental Protection Agency (EPA), and specific exposure scenarios. These estimates suggest that nitrosamine contamination in drugs that are used long-term can increase cancer risks and pose a serious concern to public health.
Insights
Nitrosamine contamination in medications like valsartan, including NDMA and NDEA, poses significant cancer risks. Long-term drug use with these contaminants raises public health concerns due to their carcinogenic properties.
Area of Science:
- Environmental Health
- Toxicology
- Pharmaceutical Science
Background:
- Nitrosamines are potent carcinogens, with over 30 listed under California's Proposition 65.
- Recent contamination of drugs for hypertension, heartburn, and diabetes has led to FDA recalls.
- Key contaminants include N-nitrosodimethylamine (NDMA), N-nitrosodiethylamine (NDEA), and N-nitroso-N-methyl-4-aminobutyric acid (NMBA).
Purpose of the Study:
- To estimate the additional cancer risks from NDMA and NDEA contamination in commonly used drugs.
- To utilize valsartan as a case study for risk assessment.
- To highlight the public health implications of nitrosamine contamination in pharmaceuticals.
Main Methods:
- Utilized US FDA reported nitrosamine levels.
- Incorporated cancer potencies from California's Proposition 65 and US EPA.
- Applied specific exposure scenarios for risk estimation.
Main Results:
- Nitrosamine contaminants like NDMA and NDEA share genotoxic and tumorigenic activities.
- These contaminants exhibit common target tumor sites.
- Estimates indicate increased cancer risks associated with long-term use of contaminated drugs.
Conclusions:
- Nitrosamine contamination in pharmaceuticals is a serious public health concern.
- Long-term exposure to contaminated drugs can elevate cancer risks.
- Regulatory oversight and monitoring are crucial for drug safety.
More Related Videos
Related Concept Videos
2° Amines to N-Nitrosamines: Reaction with NaNO2
Mutagenicity and Carcinogenicity
Physical Properties of Amines
Cancer Prevention
Some...
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Types of Toxins
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...

